It is known that key epigenetic changes in osteoporosis affect the regulation of signalling pathways involved in mesenchymal stem cell (MSC) differentiation, including the activity of the transcription factor RUNX2, sclerostin, and DKK1 [5]. Here, RUNX2 is linked to osteoporosis.